SION

Sionna Therapeutics, Inc.

Healthcare · Biotechnology

$165.35 sample

-2.24 (-1.34%) 1D

Market cap

$560.6B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-04

Alerts

8

Price$165.35 -1.25% 3M daily closessample

173.49159.19

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: General Counsel
Sep 23INSInsider sell: EVP, Operations
Sep 14INSInsider buy: 10% owner
Sep 04SEC10-Q filed
Aug 28SEC8-K filed: material event
Aug 24INSInsider sell: General Counsel
Aug 19INSInsider sell: 10% owner
Aug 10INSInsider sell: 10% owner

Sign up to see the real SION record →

Company facts

SEC EDGAR registration

Name: Sionna Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -18sample, -100 to +100
Reporting currency: USD

Who is positioning in SION

sample

Insiders: 17 insider transactions over 90 days, net selling, $30.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 30 funds hold $8.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.7B +22.1% y/y

Q4 2024Q3 2026

Inventory$19.5B +16.0% y/y

Q4 2024Q3 2026

Accounts receivable$14.7B +16.8% y/y

Q4 2024Q3 2026

Total debt$41.0B +22.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $279.8B +6.5% 3M
Sample peer B: $415.5B +11.4% 3M
Sample peer C: $241.9B +14.1% 3M
Sample peer D: $453.5B -9.1% 3M
Sample peer E: $162.4B -3.8% 3M